The largest database of trusted experimental protocols

16 protocols using ha ub

1

Engineered Plasmids for Cell Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
We mainly used pcDNA3.1 myc-His (+) B (V80020; Invitrogen) and pHR_EF1a (modified from pHR_PGK, #79120; Addgene) for transit transfection and virus packing, respectively. Human MARCH5 (including its variants), PEX3 (including its variants), PEX19 (including its variants), and PMP70 were cloned into pcDNA3.1 with a C-terminal Myc or V5 or triple FLAG tag using Gibson assembly. MARCH5-mCherry-Myc (including its variants) and PEX3-YFP (including its variants) were cloned into pcDNA3.1 and pHR_EF1a. mCherry-SKL, RFP-SKL, GFP-SKL, and GFP-RFP-SKL were cloned into pHR_EF1a. HA-Ub was purchased from Addgene (#18712). All plasmids were confirmed by Sanger sequencing.
+ Open protocol
+ Expand
2

Plasmid construction and shRNA targeting

Check if the same lab product or an alternative is used in the 5 most similar protocols
HA-Ub (WT), HA-Ub (K6) only, HA-Ub (K11) only, HA-Ub (K27) only, HA-Ub (K29) only, HA-Ub (K33) only, HA-Ub (K48) only, HA-Ub (K63) only, and HA-GASC1 were purchased from Addgene. HA-Ub (K63R) was generated by cloning the corresponding cDNAs into the pCMV-HA vector via XbaI/NotI sites. pCMV-Myc-ROCK2, pCMV-Myc-ROCK2-CAT (aa 5-553), and pCMV-Myc-ROCK2-RB/PH (aa 686-1388) were generated by subcloning the corresponding cDNAs into the pCMV-Myc vector via KpnI/XhoI or XbaI/NotI sites. HA-FBXO42 and HA-FBXO42-△F-box (deleting aa 44-93) was generated by subcloning the corresponding cDNAs into the pCMV-HA vector via XhoI/BamHI sites. pCMV-Myc-ROCK2-K121R was generated using the Quick Change Q5 Site-Directed Mutagenesis Kit (NEBaseChanger) according to the manufacturer’s instructions. The pLKO.1-puro lentiviral MISSION shRNA constructs targeting endogenous GASC1 (shGASC1 CDS1 (TRCN0000022056): sense, 5′-GCCTCTGACATGCGATTTGAA-3′, and shGASC1 CDS2 (TRCN0000022055): sense, 5′-CCTTGCATACATGGAGTCTAA-3′), FBXO42 (shFBXO42 CDS (TRCN0000134822): sense, 5′-CCATCAGTGTTATCATGGTTT-3′, and a non-targeting (NT) control shRNA (TRC1/1.5) were from Sigma-Aldrich. Details of plasmid construction are available upon request.
+ Open protocol
+ Expand
3

Trp53, LAST1 and TAZ Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies against Trp53 (#2524; dilution 1:1000), LAST1 (#3477; dilution 1:1000), pLAST1 (#8654; dilution 1:1000), TAZ (#83669; dilution 1:1000), pTAZ (#59971; dilution 1:1000), HA (#5017; dilution 1:1000), GAPDH (#5174; dilution 1:1000); cycloheximide (CHX) and insulin-transferrin-sodium selenite media supplement (ITS Supplement) were purchased from Cell Signaling Technology. BrdU (#sc-32323; dilution 1:1000), β-TrCP (#sc-390629; dilution 1:1000), GFP (#sc-9996; dilution 1:1000) and flag (#sc-7945; dilution 1:1000) antibodies were obtained from Santa Cruz Biotechnology. Col10a1 (#14-9771-80; dilution 1:1000) antibody, EDTA-free cocktail inhibitor tablets, calcein and BrdU labeling were obtained from Fisher Scientific™. The Transfection Reagent FuGENE® HD was ordered from Promega (USA). The plasmids GFP-Trp53, flag-TAZ, and HA-Ub were from Addgene (USA).
+ Open protocol
+ Expand
4

Plasmid Transfection for EIF3H Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
The wild-type and mutant constructs of EIF3H plasmids were purchased from the Hanbio Biotechnology Co., Ltd. (Shanghai, China). The HA-K48, HA-K63, and HA-Ub plasmids were acquired from Addgene. The small interfering RNAs targeting EIF3H (5ʹ-GCAACTCTTGGAAGAAATATA-3ʹ) and (5ʹ-CCCAAGGATCTCTCTCACTAA-3ʹ) were gained from Ruibo Biotechnology Co., Ltd. (Guangzhou, China). Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) was utilized for plasmid and siRNA transfection according to the manufacturer's recommendations.
+ Open protocol
+ Expand
5

Plasmids and siRNAs for Ubiquitin Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
The The full-length and deletion mutant constructs of TAZ and USP26 were obtained from Hanbio Biotechnology Co. Ltd. (Shanghai, China). The HA-K6, HA-K11, HA-K27, HA-K29, HA-K33, HA-K48, HA-K63, and HA-Ub plasmids were acquired from Addgene. Small interfering RNAs targeting USP26 (siRNA-1: 5′-GCACAAGACUUCCGUUGGA-3′; 5′-AAACAGAUCUGGUUCACUU-3′) were synthesized by Genepharma (Shanghai, China).
+ Open protocol
+ Expand
6

Cloning and Characterization of OPN-i and Bcl-6 Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
OPN-i expression vectors, pMLS5, OPN-i–Flag, and OPN-i–GFP were described previously 17 (link). A tandem HA-Flag tag was introduced at the C-terminus of OPN-i cDNA by PCR using primers containing BamHI and EcoRI sites followed by cloning into pBABE-GFP vector. Bcl-6 cDNA was obtained from Open Biosystems (Bcl-6 Clone ID: 6309948), sequenced in full, before complete coding region sequences were cloned inframe with a Flag tag at the N-terminus into retroviral expression vector MSCV-IRES-GFP. The following plasmids were obtained from Addgene: p85α (plasmid 1399 and 1407), HA-p110 (plasmid 12522 and 15691) 50 (link), 51 (link) and HA-Ub (plasmid 17608) 52 (link). Deletion constructs of Bcl-6, Flag–Bcl-6, and OPN-i Y166F mutants were generated by PCR-mediated mutagenesis with the QuickChange II XL Site-Directed Mutagenesis Kit (Agilent). The accuracy of all plasmids was confirmed by DNA sequencing. Retroviral stocks were generated by transfection of 293T cells with plasmids expressing pBABE-GFP control or pBABE-GFP plus OPN-i wild-type or OPN-i Y166F along with pCL-Eco packaging vector using TransIT-LT1 transfection reagent (Mirus). Viral supernatants were collected 72 h later before infection of CD4+ T cells, as described below.
+ Open protocol
+ Expand
7

Plasmid Transfection for Ubiquitination Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mammalian expression plasmids Flag-tagged TBK1 and V5-tagged SRA were stored in our laboratory. Flag-CYLD, Flag-TBK1 KD, ULD, SDD, CTD, 30R, 401R, and 30R/401R were obtained from BGI (BGI group, Shenzhen, China). HA-Ub, HA-Ub-K48, HA-Ub-K63, and HA-Ub-K33 were purchased from Addgene (http://www.addgene.org). The HEK293T cells were cultured in DMEM high glucose supplemented with 10% FBS. Cells were seeded in 10-cm dishes and were transfected with 10 μg plasmid with PEI (Polysciences, Warrington, PA, USA) according to the manufacturer’s instruction.
+ Open protocol
+ Expand
8

Cloning and Characterization of OPN-i and Bcl-6 Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
OPN-i expression vectors, pMLS5, OPN-i–Flag, and OPN-i–GFP were described previously 17 (link). A tandem HA-Flag tag was introduced at the C-terminus of OPN-i cDNA by PCR using primers containing BamHI and EcoRI sites followed by cloning into pBABE-GFP vector. Bcl-6 cDNA was obtained from Open Biosystems (Bcl-6 Clone ID: 6309948), sequenced in full, before complete coding region sequences were cloned inframe with a Flag tag at the N-terminus into retroviral expression vector MSCV-IRES-GFP. The following plasmids were obtained from Addgene: p85α (plasmid 1399 and 1407), HA-p110 (plasmid 12522 and 15691) 50 (link), 51 (link) and HA-Ub (plasmid 17608) 52 (link). Deletion constructs of Bcl-6, Flag–Bcl-6, and OPN-i Y166F mutants were generated by PCR-mediated mutagenesis with the QuickChange II XL Site-Directed Mutagenesis Kit (Agilent). The accuracy of all plasmids was confirmed by DNA sequencing. Retroviral stocks were generated by transfection of 293T cells with plasmids expressing pBABE-GFP control or pBABE-GFP plus OPN-i wild-type or OPN-i Y166F along with pCL-Eco packaging vector using TransIT-LT1 transfection reagent (Mirus). Viral supernatants were collected 72 h later before infection of CD4+ T cells, as described below.
+ Open protocol
+ Expand
9

Transfecting Src, HIF-1α, and Ubiquitin

Check if the same lab product or an alternative is used in the 5 most similar protocols
HA-HIF-1α, HA-Ub, and pcDNA3-Src plasmids were purchased from Addgene (Watertown, MA, USA). Small interfering RNAs (siRNAs) targeting Src were purchased from Santa Cruz Biotechnology. Cells were transiently transfected with plasmids or siRNAs using Lipofectamine 2000 or RNA iMAX reagents (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
10

Molecular Interactions in USP11 and Sirt3 Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human Flag-USP11, Flag-USP11-C318S, HA-Ubiquitin (Ub) and HA-Ub mutants were purchased from Addgene (MA, USA). The protein information of USP11 (UniProt ID: P51784) and Sirt3 (UniProt ID: Q9NTG7) was acquired from UniProt website (https://www.uniprot.org/). Then the coding sequence (CDS) of USP11 (GenBank ID: BC140849.1) and Sirt3 (GenBank ID: AF083108.2) was obtained from National Center for Biotechnology Information (https://www.ncbi.nlm.nih.gov/). The full-length sequence or different domain sequences of USP11 and Sirt3 were synthesized and subcloned into Flag-, or Myc-tagged pEX-3 (pGCMV/MCS/Neo) vectors by GenePharma Biotechnology Co., LTD (Shanghai, China). Human NP cells or Human embryonic kidney T cells (HEK 293 T cells, purchased from QuickCell, China) were transfected with above plasmid using Lipo8000™ reagent (C0533, Beyotime, China). Briefly, the day before transfection, the cells were seeded in 6-well plates (about 5 × 104 cells per well). The culture medium was changed when the cells reached 80% confluence. Added the mixture with the amount of 130 μl (125 μl of Opti-MEM + 2.5 μg of DNA + 4 μl of Lipo8000™ reagent) into each well, and incubated for 24 h.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!